Solstein Capital, LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 452 filers reported holding VANECK VECTORS ETF TR in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.

Quarter-by-quarter ownership
Solstein Capital, LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q2 2021$7,000
-91.6%
195
-90.8%
0.01%
-95.2%
Q3 2020$83,000
-92.1%
2,125
-92.5%
0.19%
-92.5%
Q2 2020$1,046,000
+459.4%
28,517
+346.3%
2.48%
+558.6%
Q4 2019$187,000
-0.5%
6,390
-41.9%
0.38%
-77.4%
Q3 2019$188,000
+46.9%
11,000
+120.0%
1.67%
+103.3%
Q2 2019$128,000
-57.8%
5,000
-63.0%
0.82%
-52.0%
Q1 2019$303,00013,5001.71%
Other shareholders
VANECK VECTORS ETF TR shareholders Q1 2019
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$20,220,00066.82%
Baymount Management LP 145,000$3,970,00028.08%
New Harbor Financial Group, LLC 1,371,341$37,547,00018.51%
New Harbor Financial Group, LLC 1,291,700$35,366,00017.44%
MKP Capital Management, L.L.C. 1,500,000$41,070,00013.74%
Windmill Hill Asset Management Ltd 844,600$23,125,00011.94%
Hollow Brook Wealth Management LLC 768,567$21,043,00011.57%
Grand Central Investment Group 261,915$7,171,00010.33%
Point72 Europe (London) LLP 1,467,000$40,166,0008.50%
Slate Path Capital LP 4,600,000$125,948,0007.87%
View complete list of VANECK VECTORS ETF TR shareholders